The impact of angiogenesis inhibitors on survival of patients with small cell lung cancer

The impact of angiogenesis inhibitors on survival of patients with small cell lung cancer

Abstract Background Small cell lung cancer (SCLC) is a highly invasive and lethal neuroendocrine tumor. Antiangiogenic drugs have been reported in the treatment of SCLC. We aimed to provide a comprehensive evaluation of the impact of angiogenic inhibitors on SCLC survival using network meta‐analysis...

Full description

Bibliographic Details
Main Authors:	Xiaoshun Shi, Xiaoying Dong, Sylvia Young, Allen Menglin Chen, Xiguang Liu, Zhouxia Zheng, Kailing Huang, Di Lu, Siyang Feng, Grant Morahan, Kaican Cai
Format:	Article
Language:	English
Published:	Wiley 2019-10-01
Series:	Cancer Medicine
Subjects:	angiogenesis inhibitors network meta‐analysis randomized controlled trial small cell lung cancer target drugs
Online Access:	https://doi.org/10.1002/cam4.2462

Similar Items

ANGIOGENESIS INHIBITORS FOR THE TREATMENT OF HEPATOCELLULAR CARCINOMA
by: Massimiliano Berretta, et al.
Published: (2016-11-01)

Angiogenesis in glioma
by: Fei-Yi-Fan Wang, et al.
Published: (2018-01-01)

Cancer susceptibility genes: update and systematic perspectives
by: Xiaoshun Shi, et al.
Published: (2022-09-01)

Successes and failures of angiogenesis blockade in gastric and gastro-esophageal junction adenocarcinoma
by: Massimiliano Salati, et al.
Published: (2022-09-01)

Current Evidence of the Efficacy and Safety of Neoadjuvant EGFR-TKIs for Patients With Non-small Cell Lung Cancer
by: Xiaoshun Shi, et al.
Published: (2021-05-01)

IRGS: an immune-related gene classifier for lung adenocarcinoma prognosis
by: Xiaoshun Shi, et al.
Published: (2020-02-01)

Growth factor for therapeutic angiogenesis in ischemic heart disease: A meta-analysis of randomized controlled trials
by: Ling Tan, et al.
Published: (2022-12-01)

Angiogenesis and the Models to Study Angiogenesis
by: Ali Mostafaie, et al.
Published: (2010-01-01)

Molecular facets and biochemical cross-talk of angiogenesis: Potential therapeutic targets
by: Jinnenahalli Raju Yodhaanjali, et al.
Published: (2022-01-01)

Future Perspectives of Therapeutic, Diagnostic and Prognostic Aptamers in Eye Pathological Angiogenesis
by: Emilio Iturriaga-Goyon, et al.
Published: (2021-06-01)

Angiogenesis Inhibitors and Immunomodulation in Renal Cell Cancers: The Past, Present, and Future
by: Lawrence Kasherman, et al.
Published: (2022-03-01)

Editorial: Angiogenesis and Angiogenesis Inhibitors in Oral Cancer
by: Abdelhakim Salem, et al.
Published: (2021-12-01)

Combination therapy versus gemcitabine monotherapy in the treatment of elderly pancreatic cancer: a meta-analysis of randomized controlled trials
by: Jin JM, et al.
Published: (2018-03-01)

Immunopathogenetic mechanisms of skin toxic response of antitumor therapy with mul-tikinase of angiogenesis inhibitors
by: Shatokhina Е.А., et al.
Published: (2017-09-01)

Trends, Symptoms, and Outcomes of Resectable Giant Mediastinal Tumors
by: Xiaoshun Shi, et al.
Published: (2022-02-01)

Mechanisms of Action of Novel Drugs Targeting Angiogenesis-Promoting Matrix Metalloproteinases
by: Gregg B. Fields, et al.
Published: (2019-06-01)

Novel Angiogenic Regulators and Anti-Angiogenesis Drugs Targeting Angiogenesis Signaling Pathways: Perspectives for Targeting Angiogenesis in Lung Cancer
by: Yingying Li, et al.
Published: (2022-03-01)

Endogenous Matrix-Derived Inhibitors of Angiogenesis
by: Hans Petter Eikesdal, et al.
Published: (2010-09-01)

Antioxidants stimulate BACH1-dependent tumor angiogenesis
by: Ting Wang, et al.
Published: (2023-10-01)

The Effect of Capsaicin on the Viability and Angiogenesis of Random-Pattern Skin Flaps
by: Mehmet Ersin Gönüllü, et al.
Published: (2021-01-01)

Efficacy and safety of EGFR-TKIs in combination with angiogenesis inhibitors as first-line therapy for advanced EGFR-mutant non-small-cell lung cancer: a systematic review and meta-analysis
by: Di Hu, et al.
Published: (2023-06-01)

A Novel Angiogenesis Inhibitor Bevacizumab Induces Apoptosis in the Rat Endometriosis Model
by: Soysal D., et al.
Published: (2014-12-01)

The correlation between the influencing factors and efficacy of immune checkpoint inhibitor therapy: an umbrella meta-analysis of randomized controlled trials
by: Dahai Hu, et al.
Published: (2023-12-01)

Obesity and Angiogenesis
by: Zoya Tahergurabi, et al.
Published: (2012-03-01)

Tigeciclina en infecciones intraabdominales complicadas
by: Johanna Osorio, et al.

Clinical Application of Novel Therapies for Coronary Angiogenesis: Overview, Challenges, and Prospects
by: Mohamed Sabra, et al.
Published: (2021-04-01)

Angiogenesis: A Pivotal Therapeutic Target in the Drug Development of Gynecologic Cancers
by: Lawrence Kasherman, et al.
Published: (2022-02-01)

Angiogenesis and Its Targeting in Glioblastoma with Focus on Clinical Approaches
by: Fatemeh Daneshimehr, et al.
Published: (2022-10-01)

Targeting OPA1-Mediated Mitochondrial Fusion Contributed to Celastrol’s Anti-Tumor Angiogenesis Effect
by: Gaofu Li, et al.
Published: (2022-12-01)

Does the use of targeted agents in advanced gastroesophageal cancer increase complete response? A meta-analysis of 18 randomized controlled trials
by: Pang Y, et al.
Published: (2018-11-01)

Fatal adverse events with molecular targeted agents in the treatment of advanced hepatocellular carcinoma: a meta-analysis of randomized controlled trials
by: Li X, et al.
Published: (2018-09-01)

Machine Learning Models to Predict Primary Sites of Metastatic Cervical Carcinoma From Unknown Primary
by: Di Lu, et al.
Published: (2020-12-01)

Rivastigmine Regulates the HIF-1α/VEGF Signaling Pathway to Induce Angiogenesis and Improves the Survival of Random Flaps in Rats
by: Yingying Liu, et al.
Published: (2022-01-01)

Therapeutic potential of pravastatin for random skin flaps necrosis: involvement of promoting angiogenesis and inhibiting apoptosis and oxidative stress
by: Lin J, et al.
Published: (2019-05-01)

Marine-Derived Angiogenesis Inhibitors for Cancer Therapy
by: Ying-Qing Wang, et al.
Published: (2013-03-01)

Clinicopathological features, survival outcomes, and appropriate surgical approaches for stage I acinar and papillary predominant lung adenocarcinoma
by: Di Lu, et al.
Published: (2020-05-01)

Preliminary results of the European multicentric phase III trial regarding sirolimus in slow-flow vascular malformations
by: Emmanuel Seront, et al.
Published: (2023-11-01)

Editorial: Key proteins of tumor angiogenesis: potential therapeutic targets for gastrointestinal tumors
by: Weilong Zhong
Published: (2024-03-01)

Co-Targeting Tumor Angiogenesis and Immunosuppressive Tumor Microenvironment: A Perspective in Ethnopharmacology
by: Jianbo Zhou, et al.
Published: (2022-06-01)

Tumor angiogenesis regulators /
by: Gonzalez-Perez, Ruben R editor, et al.
Published: (c201)